Showing 1 - 7 of 7
Persistent link: https://www.econbiz.de/10003665715
Persistent link: https://www.econbiz.de/10009701926
Persistent link: https://www.econbiz.de/10001880835
Persistent link: https://www.econbiz.de/10001249274
We analyze the financial performance of a hypothetical portfolio of 120 mRNA vaccine candidates in the preclinical stage targeting 11 emerging infectious diseases. We calibrate the simulation parameters with input from domain experts in mRNA technology and an extensive literature review. We find...
Persistent link: https://www.econbiz.de/10013334345
Persistent link: https://www.econbiz.de/10013361693
Persistent link: https://www.econbiz.de/10004999520